Ethnic differences in thromboprophylaxis for COVID-19 patients: should they be considered?

Thromboembolic events contribute to morbidity and mortality in coronavirus disease 2019 (COVID-19). As a result, thromboprophylaxis using low-molecular-weight heparin (LMWH) is universally recommended for hospitalized patients based on multiple guidelines. However, ethnic differences with respect to...

Full description

Saved in:

Bibliographic Details
Published in:	International journal of hematology Vol. 113; no. 3; pp. 330 - 336
Main Authors:	Iba, Toshiaki, Connors, Jean Marie, Spyropoulos, Alex C., Wada, Hideo, Levy, Jerrold H.
Format:	Journal Article
Language:	English
Published:	Singapore Springer Singapore 01.03.2021 Springer Nature B.V
Subjects:	Anticoagulants Anticoagulants - administration & dosage Anticoagulants - adverse effects Biological Variation, Population Bleeding Coronaviruses COVID-19 COVID-19 - complications COVID-19 - epidemiology COVID-19 - virology Cultural differences Disease Management Disease Susceptibility Ethnicity Hematology Heparin Humans Medicine Medicine & Public Health Minority & ethnic groups Morbidity Mortality Oncology Post-Exposure Prophylaxis Prognosis Review Review Article SARS-CoV-2 Thromboembolism Thromboembolism - diagnosis Thromboembolism - epidemiology Thromboembolism - etiology Thromboembolism - prevention & control Thrombosis Venous Thromboembolism - etiology Venous Thromboembolism - prevention & control Viral diseases COVID-19 Ethnic difference Deep vein thrombus Thromboprophylaxis Thromboembolism
ISSN:	0925-5710, 1865-3774, 1865-3774
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!